David Ketteridge-Tan is a Director in the Life Sciences investment team at Temasek. He is based in London and covers EMEA investments across biopharma, LS tools & diagnostics, and pharma services. He focuses on later-stage venture and growth equity investments and manages both private and public portfolio companies. David is a CFA charterholder and has a PhD in Molecular and Cell Biology from the University of Cambridge.